Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Signaling

Background:

• Epidermal growth factor receptor (EGFR) is crucial for development and implicated in various cancers.
• The intricate allosteric regulation of EGFR is not fully understood, particularly the loss of negative cooperativity in its extracellular region (ECR).

Purpose of the Study:

• To investigate the relationship between ligand binding and receptor dimerization in EGFR.
• To elucidate the mechanisms underlying EGFR allosteric regulation and the impact of oncogenic mutations.

Main Methods:

• Studied the extracellular region (ECR) of EGFR.
• Analyzed ligand binding and receptor dimerization dynamics.
• Investigated the structural consequences of forcing EGFR ECR into preformed dimers.
• Examined the effect of glioblastoma-associated EGFR mutations on ligand binding and dimerization.

Main Results:

• Ligand binding and EGFR dimerization were found to compete, with ligand binding promoting dimerization rather than vice versa.
• Forcing EGFR ECRs into dimers without ligand resulted in unstable, heterogeneous structures.
• EGFR-activating mutations in glioblastoma increased ligand-binding affinity but did not directly induce dimerization.

Conclusions:

• EGFR allosteric regulation involves a competitive interplay between ligand binding and dimerization.
• Oncogenic EGFR mutations may disrupt the allosteric linkage between dimerization and ligand binding, impacting receptor activation.
• These findings offer new insights into EGFR activation by ligands and pathological mutations.